This is one of the biggest cohort ATUs in metastatic breast cancer with more than 700 women in 12 months receiving an innovative treatment prior to marketing authorisation. Axonal-Biostatem has set up an ATU cell for managing the requirements of treatment multiple times a day (pre-validation of treatment eligibility criteria, transmission [...]
